1-8 of 8
quinine 3-monooxygenase, human
Close
Sort by
Journal Articles

Population Pharmacokinetics of Ivosidenib (AG-120) in Patients with IDH1-Mutant Advanced Hematologic Malignancies

Kha Le, PhD, Russ Wada, PhD, David Dai, PhD, Bin Fan, PhD, Guowen Liu, PhD, Hua Liu, PhD, Eyal C. Attar, MD, Samuel V. Agresta, MD, Hua Yang, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1394.
https://doi.org/10.1182/blood-2018-99-109863
Published: 2018
Journal Articles

Concomitant Use of Midostaurin with Strong CYP3A4 Inhibitors: An Analysis from the Ratify Trial

Taoufik Ouatas, PhD, Vincent Duval, PharmD, Karen Sinclair, PhD, Noah Berkowitz, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3814.
https://doi.org/10.1182/blood.V130.Suppl_1.3814.3814
Published: 2017
Journal Articles

Major Bleeding with Ibrutinib: More Than Expected

Paul R Kunk, MD, Joesph Mock, MD, Michael E. Devitt, MD, Surabhi Palkimas, Pharm D., Jeremy Sen, Pharm D., Craig A. Portell, MD, Michael E. Williams, MD
Journal: Blood
Blood (2016) 128 (22): 3229.
https://doi.org/10.1182/blood.V128.22.3229.3229
Published: 2016
Journal Articles

Effects of Renal Function on the Pharmacokinetics of Panobinostat in Patients with Advanced Cancer: A Phase I Study

Sunil Sharma, MD, Emile Voest, MD, PhD, Nicole Hagner, MD, P.O. Witteveen, MD, PhD, Martijn Lolkema, MD, PhD, Neeraj Agarwal, MD, Sue-zette Valera, Jason Li, PhD, Derek Mires, Maria Grazia Porro, PhD, Margaret M. Woo, PharmD, Dagmar Hess, MD
Journal: Blood
Blood (2011) 118 (21): 5001.
https://doi.org/10.1182/blood.V118.21.5001.5001
Published: 2011
Journal Articles

Effects of Hepatic Function on the Pharmacokinetics and Safety of Panobinostat in Patients with Advanced Cancer: A Phase I Study

Dagmar Hess, MD, Nicole Hagner, MD, Sally Clive, MD, Hans Gelderblom, MD, PhD, Eva Rossmann, MD, PhD, Neeraj Agarwal, MD, Maria Grazia Porro, PhD, Thomas Hengelage, PhD, Annie St-Pierre, PhD, Lucien Gazi, PhD, Jason Li, PhD, Margaret M. Woo, PharmD, Sunil Sharma, MD
Journal: Blood
Blood (2011) 118 (21): 5007.
https://doi.org/10.1182/blood.V118.21.5007.5007
Published: 2011
Journal Articles

Effect of the Cytochrome P450 3A4 Inducers, Rifampicin and Dexamethasone, on the Pharmacokinetic, Pharmacodynamic and Safety Profile of Bortezomib In Patients with Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL)

Andrzej Hellmann, Simon A. Rule, Jan Walewski, Ofer Shpilberg, Huaibao Feng, Helgi van de Velde, Hamina Patel, Donna M Skee, Suzette Girgis, Vernon Louw
Journal: Blood
Blood (2010) 116 (21): 3983.
https://doi.org/10.1182/blood.V116.21.3983.3983
Published: 2010
Journal Articles

Life-Threatening Complications Suspected Due to Clinical Pharmacokinetic Interaction Between Cyclosporine A and Triazole Antifungal Agents in Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) Recipients.

Ting Yang, Danhui Fu, Jianda Hu, Xiaoyun Zheng, Xiaofeng Luo, Hongqiang Qiu, Xuemei Wu, Ruling Chen, Zhizhe Chen
Journal: Blood
Blood (2009) 114 (22): 4319.
https://doi.org/10.1182/blood.V114.22.4319.4319
Published: 2009
Journal Articles

Prolonged Administration of Aprepitant Does Not Increase Toxicity in Patients Undergoing High Dose Chemotherapy and Autologous Stem Cell Transplant.

Mehnaz Junagadhwalla, MD, Joanne Chilton, CRA, Teresa Gentile, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 5329.
https://doi.org/10.1182/blood.V106.11.5329.5329
Published: 2005